GSIG Journal Club March 15, 2012. Chemical carcinogens Farazi & DePinho, Nat Rev Can, 2006 Hepatocellular carcinoma (HCC) Malignant adult tumor with.

Slides:



Advertisements
Similar presentations
Cytokines, inflammation and cancer Alexandre Corthay Department of Immunology Oslo University Hospital Rikshospitalet and University of Oslo Oslo, Norway.
Advertisements

Introduction to Immunology BIOS 486A/586A Kenneth J. Goodrum,Ph.D. Department of Biomedical Sciences Ohio University 2005.
Dental Microbiology #211 IMMUNOLOGY 2006 Lecture 2 The Lymphocytes.
Tumor Immunology (I): Cancer Immunosurveillance & Immunoediting Masoud H. Manjili Department of Microbiology & Immunology Goodwin Research Building-286.
Immunity : The Immune system plays a role in combating infection, creating inflammation (& consequently heart disease), controlling (or not) cancer and.
118/2/2015 Cancer & the Immune System Hugh B. Fackrell.
Tumor Immunology: Definitions: -Tumor (neoplasm): unchecked cellular growth. -Two types: 1-Benign: controlled tumor. 2-Malignant: uncontrolled tumor. -Malignant.
TUMOR IMMUNOLOGY Objectives
بسم الله الرحمن الرحيم. Cancer Origin and Terminology Malignant Transformation of Cells Oncogenes and Cancer Induction Tumor Antigens Immune Responses.
Specific Defenses of the Host
The immune response White Blood cell types. Myeloid stem cells Lymphoid cells Pluripotent stem cells (in bone marrow) Monocyte Mast cells Basophils Neutrophils.
Lecture #10 Aims Describe T cell maturation and be able to differentiate naïve and effector T cells. Differentiate the development and functions of Th1.
Dental Microbiology #211 IMMUNOLOGY Lecture 2. Topics The B and T Lymphocytes Antigen-specific Receptors on B and T cells CD4+ and CD8+ T cells Cytokines.
Host Defense Against Tumors (Tumor Immunity)
NAJRAN UNIVERSITY College of Medicine NAJRAN UNIVERSITY College of Medicine Microbiology &Immunology Course Lecture No. 15 Microbiology &Immunology Course.
Cancer and the Immune System
HOST DEFENCE AGAINST TUMORS:
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
STAT4 Knockout Mice Are More Susceptible to Concanavalin A–Induced T-Cell Hepatitis  Yan Wang, Dechun Feng, Hua Wang, Ming-Jiang Xu, Ogyi Park, Yongmei.
The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Experimental Models of Inflammatory Bowel Diseases
Cancer and the Immune System
Volume 151, Issue 5, Pages (November 2016)
Avoiding Immune Detection
Immunological memory Topics Immune regulation  T cells
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice by Robert G. Newman,
Msc clinical immunology
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer.
Volume 131, Issue 1, Pages (July 2006)
Lymphoid system.
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Volume 150, Issue 3, Pages (March 2016)
Nat. Rev. Rheumatol. doi: /nrrheum
Volume 25, Issue 4, Pages (April 2014)
DNA Damage-Mediated Induction of a Chemoresistant Niche
Volume 131, Issue 1, Pages (July 2006)
Volume 132, Issue 4, Pages (April 2007)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Volume 29, Issue 4, Pages (April 2016)
Volume 20, Issue 6, Pages (December 2011)
Volume 16, Issue 4, Pages (April 2002)
Volume 143, Issue 1, Pages e7 (July 2012)
Jia Guo, MD, Xin Lin, PhD, Marc A
DNA Damage-Mediated Induction of a Chemoresistant Niche
Impaired Th2 Subset Development in the Absence of CD4
Heather L Maecker, Zhong Yun, Holden T Maecker, Amato J Giaccia 
Volume 19, Issue 6, Pages (June 2011)
STAT1 acts as a tumor promoter for leukemia development
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 20, Issue 3, Pages (March 2004)
Volume 127, Issue 3, Pages (September 2004)
Volume 35, Issue 1, Pages (July 2011)
Volume 27, Issue 3, Pages (September 2007)
Volume 30, Issue 4, Pages (October 2016)
Th1 and Th2 immune responses
Volume 5, Issue 6, Pages (June 2002)
Volume 30, Issue 4, Pages (October 2016)
Volume 17, Issue 9, Pages (November 2016)
Volume 31, Issue 4, Pages (October 2009)
Volume 3, Issue 2, Pages (February 2003)
Inflaming the CD8+ T Cell Response
Elimination of CD4+ T Cells Enhances Anti-Tumor Effect of Locally Secreted Interleukin- 12 on B16 Mouse Melanoma and Induces Vitiligo-Like Coat Color Alteration 
Arp2/3-mediated formation of nuclear actin networks is essential for CD4+ T cell effector functions. Arp2/3-mediated formation of nuclear actin networks.
Volume 34, Issue 3, Pages (March 2011)
Javed Mohammed, Andrew Ryscavage, Rolando Perez-Lorenzo, Andrew J
Volume 20, Issue 3, Pages (March 2012)
Volume 8, Issue 3, Pages (August 2014)
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma  Myoung Sook Han, Tamera Barrett, Michael.
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

GSIG Journal Club March 15, 2012

Chemical carcinogens Farazi & DePinho, Nat Rev Can, 2006 Hepatocellular carcinoma (HCC) Malignant adult tumor with multiple suspected origins- hepatocyte, biliary, or adult progenitor cells, occurs at age 50+, incidence of ~5/100,000 (US) and rising (HCV) 90% of primary liver cancers in US, 7 th most common cancer globally, 3 rd leading cause of cancer mortality globally 10% survival at 5 yrs

Effector loop mutant

Presumably, all Nras G12V+ cells are senescent and express pERK, p21 and p16 (double stains or serial sections would have been helpful).

Whole liver lysates Purified hepatocytes

Increased infiltration of immune cells in Nras G12V livers

Suppl Figure 6 | Immunohistochemical staining of immune cell infiltrates surrounding senescent hepatocytes in C57BL/6 mouse livers stably transduced with NrasG12V. Murine livers were harvested on day 12 after intrahepatic delivery of oncogenic Nras and paraffin sections were stained and analyzed for the indicated markers to identify NASDCL-positive cells (granulocytes and monocytes); CD3+ T lymphocytes and CD68+ histiocytes (macrophages) (400X).

Disappearance of Nras G12V+ cells in liver Disappearance not caused by apoptosis

Figure 3 | Impaired senescence surveillance results in liver cancer development. a, Experimental setup and description of immune status of C.B-17 WT, C.B-17 SCID and C.B-17 SCID/beige mice. b–e, Quantification of Nras- (b), p21- (c), p-Erk- (d) and p16-positive cells (e) on liver sections from indicated mice after stable intrahepatic delivery of NrasG12V. Values represent mean +/-s.d. (n=4). Clearance of Nras G12V+ senescent cells requires an adaptive immune response

Nras G12V+ cells may escape senescence by day 30 in CB 17 SCID mice livers

Suppl Figure 9 | Histopathological analyses detect early hepatocellular carcinomas (HCC) in mice. a, H&E staining of liver sections from C.B-17 (left), C.B-17 SCID (middle) and C.B-17 SCID/beige mice (right) 3 months after stable intrahepatic delivery of NrasG12V via transposable elements. Shown liver section of a C.B-17 mouse reveals normal acinar architecture (left, 100X). Livers of C.B-17 SCID (middle) and C.B-17 SCID/beige (right) mice show dysplastic nodules (DN), a bona fide precursor lesion of HCC. Fig 3f. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of HCC in C.B-17 SCID and C.B-17 SCID/beige mice 7 months following NrasG12V transduction. Shown are representative photographs of explanted livers (n=10). Arrows, intrahepatic tumour nodules. Values represent mean +/-s.d. of macroscopically detectable tumour nodules bigger than 3mm in diameter. HCC arises when senescence surveillance is impaired

How do they know the IFN production is T cell mediated? What cells are producing IFN? Are T-cells recognizing G12V peptide as an Ag presented by senescent hepatocytes? Ag specific T cell activation by peptides expressed in Nras G12V hepatocytes

Figure 4 p19 Arf is required to induce senescence. In its absence, Ag specific T cell response not induced. Intrahepatic delivery of NrasG12V into p19Arf-/- mice caused rapid onset of invasive HCC, which was independent of the CD4 + T-cell status T cell activation requires a functional senescence program.

Senescence surveillance occurs in Tak -/- (inflammation) and DEN (toxicity) models of HCC Suppl Figure 21Suppl Figure 22 Rag -/- mice are deficient in CD4 and CD8 cells

Figure 4 Suppl Figure 23 Professional APCs sufficient for T cell activation but senescence surveillance requires both professional and hepatocyte Ag presentation To distinguish whether senescent hepatocytes can directly present antigens and prime CD4+ T cells or whether antigen presentation occurs via professional APCs, we stably co-delivered oncogenic NrasG12V and ovalbumin (Ova) as a model antigen (NrasG12V-Ova) into mice with liver specific MHCII deficiency (transplantation of wt C57BL/6 BM into sublethally irradiated MHCII-/- mice) or into mice with normal hepatic MHCII expression and MHCII-/- BM (syngeneic transplantation of MHCII-/- BM into sublethally irradiated C57BL/6 wt mice). Subsequently, CFSE-labeled transgenic CD4+ T lymphocytes (OT-II, isolated from transgenic mice, which T cell receptor (TCR) is able to recognize the Ova peptide presented in the context of I-Ab) were administered and proliferation of these cells was quantified after five days

Senescence surveillance requires infiltration of nonresident macrophages and monocytes Gadolinium depletes macrophages and affects monocytes Ly-6G antibody depletes neutrophils Anti-asialo antibody depletes natural killer cells (Ly-6G/Ly-6C) antibody depletes neutrophils and monocytes, but not tissue-resident macrophages (Kupffer cells of the liver)

Impaired senescence surveillance in HCV-infected individuals that are immunosuppressed or HIV+ Quantified senescent cells in patients infected with hepatitis C virus (HCV) with or without concomitant human immunodeficiency virus (HIV) infection (impaired CD41 T-cell function) and in a unique cohort of patients who underwent two subsequent liver transplantations due to HCV-induced liver cirrhosis with a comparable grade of liver damage.

Concluding remarks and questions Removal of senescent cells in the liver is required to prevent or attenuate HCC. Process requires activated CD4 + T cells and monocytes/macrophages Do the senescent cells escape senescence and give rise to HCC or cause neighbors to become carcinogenic? Possibly “escaping cells initiate the senescence program (and thus display senescence markers) but never achieve the final state… or “factors secreted from pre-malignant senescent hepatocytes also contribute to the oncogenic transformation of neighbouring cells. How do T cells recognize senescent cells- are there particular antigens presented or cytokines secreted? How specific is T-cell mediated killing- are any neighboring normal cells eliminated as well?